rs372229032

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_001003787.4(STRADA):​c.922G>A​(p.Glu308Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000166 in 1,597,924 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E308E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00017 ( 1 hom. )

Consequence

STRADA
NM_001003787.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.37

Publications

2 publications found
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13067394).
BP6
Variant 17-63704519-C-T is Benign according to our data. Variant chr17-63704519-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 468889.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000141 (21/149148) while in subpopulation NFE AF = 0.00031 (21/67696). AF 95% confidence interval is 0.000208. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001003787.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
NM_001003787.4
MANE Select
c.922G>Ap.Glu308Lys
missense
Exon 11 of 13NP_001003787.1Q7RTN6-1
STRADA
NM_001363786.1
c.898G>Ap.Glu300Lys
missense
Exon 11 of 13NP_001350715.1
STRADA
NM_001363787.1
c.835G>Ap.Glu279Lys
missense
Exon 9 of 11NP_001350716.1A0A1W2PPJ9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
ENST00000336174.12
TSL:1 MANE Select
c.922G>Ap.Glu308Lys
missense
Exon 11 of 13ENSP00000336655.6Q7RTN6-1
STRADA
ENST00000375840.9
TSL:1
c.748G>Ap.Glu250Lys
missense
Exon 10 of 12ENSP00000365000.4Q7RTN6-5
STRADA
ENST00000392950.9
TSL:1
c.811G>Ap.Glu271Lys
missense
Exon 9 of 9ENSP00000376677.4Q7RTN6-2

Frequencies

GnomAD3 genomes
AF:
0.000141
AC:
21
AN:
149148
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000310
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000124
AC:
30
AN:
242468
AF XY:
0.000153
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000962
Gnomad NFE exome
AF:
0.000247
Gnomad OTH exome
AF:
0.000170
GnomAD4 exome
AF:
0.000169
AC:
245
AN:
1448776
Hom.:
1
Cov.:
44
AF XY:
0.000161
AC XY:
116
AN XY:
719562
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33322
American (AMR)
AF:
0.00
AC:
0
AN:
44168
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25208
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84692
European-Finnish (FIN)
AF:
0.000134
AC:
7
AN:
52422
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.000210
AC:
232
AN:
1104338
Other (OTH)
AF:
0.000100
AC:
6
AN:
59730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000141
AC:
21
AN:
149148
Hom.:
0
Cov.:
31
AF XY:
0.000179
AC XY:
13
AN XY:
72468
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40614
American (AMR)
AF:
0.00
AC:
0
AN:
14382
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4990
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4728
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000310
AC:
21
AN:
67696
Other (OTH)
AF:
0.00
AC:
0
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000114
Hom.:
0
Bravo
AF:
0.0000907
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0000741
AC:
9

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)
-
-
1
Polyhydramnios, megalencephaly, and symptomatic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.069
T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.46
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
PhyloP100
4.4
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.073
Sift
Benign
0.23
T
Sift4G
Benign
0.52
T
Polyphen
0.16
B
Vest4
0.57
MVP
0.52
MPC
0.53
ClinPred
0.075
T
GERP RS
2.8
PromoterAI
-0.026
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.065
gMVP
0.41
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372229032; hg19: chr17-61781879; API